Please login to the form below

Not currently logged in

Bedgebury win Levemir account

Bedgebury Communications has been appointed by Novo Nordisk to work on the Levemir UK advertising account

Bedgebury Communications has been appointed by Novo Nordisk to work on the Levemir (insulin detemir [rDNA origin] injection) UK advertising account.

Commenting on the recent win, John Russell, Director at Bedgebury Communications, said: "We are delighted to be working with Novo Nordisk on this exciting brand and are confident that our creativity, strategic capabilities, market insight and unrivalled attitude to service will help us to deliver real value to Levemir."

Bedgebury focuses on offering a results-lead communications service, encompassing strategy development, origination and execution of creative concepts and med-ed programmes designed to address key market opportunities.

30th September 2009


Featured jobs

Subscribe to our email news alerts


Add my company
OPEN Access Consulting

OPEN Access Consulting is a specialist market access agency within the OPEN Health Group. As value communications experts we specialise...

Latest intelligence

OUTiCO win Best in UK Pharmaceutical Outsourcing award
The Corporate LiveWire Healthcare and Life Sciences Awards celebrate global companies and individuals who have excelled over the past 12 months....
Artificial Intelligence in Healthcare
Artificial intelligence is already out-diagnosing experts, but would you put a computer in charge of your healthcare? The good, the bad; we take a look....
World Pancreatic Cancer Day 2018: Combating misconceptions in pancreatic cancer
Patients diagnosed with pancreatic cancer face a dismal prognosis, with the disease having the lowest survival rate of all major cancers. In spite of this, pancreatic cancer research is chronically...